Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Edwards Lifesciences Corp shares valued at $508,803 were sold by Ullem Scott B. on May 21 ’24. At $90.45 per share, Ullem Scott B. sold 5,625 shares. The insider’s holdings dropped to 30,561 shares worth approximately $2.67 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, BOBO DONALD E JR sold 5,000 shares, netting a total of over 439,038 in proceeds. Following the sale of shares at $87.81 each, the insider now holds 47,750 shares.
Before that, Lippis Daniel J. had sold 857 shares from its account. In a trade valued at $73,359, the CVP, JAPAC traded Edwards Lifesciences Corp shares for $85.60 each. Upon closing the transaction, the insider’s holdings decreased to 857 shares, worth approximately $2.09 million.
As published in a research note from Citigroup on May 22, 2024, Edwards Lifesciences Corp [EW] has been rated up from a Neutral to a Buy and the price target has been revised to $105 from $98. Analysts at Deutsche Bank upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in mid May. As of March 07, 2024, BofA Securities has increased its “Neutral” rating to a “Buy” for EW. Earlier on February 02, 2024, Wells Fargo upgraded its rating. Their new recommendation was “an Overweight” for EW stock which previously was a “an Equal weight”.
Analyzing EW Stock Performance
During the last five days, there has been a drop of approximately -2.94%. Over the course of the year, Edwards Lifesciences Corp shares have jumped approximately 14.70%. Shares of the company reached a 52-week high of $96.12 on 03/28/24 and a 52-week low of $71.67 on 01/04/24. A 50-day SMA is recorded $89.72, while a 200-day SMA reached $78.66. Nevertheless, trading volume fell to 2.47 million shares from 2.27 million shares the previous day.
Support And Resistance Levels for Edwards Lifesciences Corp (EW)
According to the 24-hour chart, there is a support level at 86.27, which, if violated, would cause prices to drop to 85.09. In the upper region, resistance lies at 89.42. The next price resistance is at 91.39. RSI (Relative Strength Index) is 47.66 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.59, which suggests the price will increase in the coming days. Percent R is at 61.62%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
